Eversheds Sutherland has a wide-ranging practice across both life sciences and healthcare fields. Team members from the corporate, commercial and real estate departments have a significant focus on life sciences, which includes transactional and regulatory engagements. The practice has continued to work on major M&A transactions, venture capital fundraisings and commercial contracts in the life sciences sector. In healthcare, the firm remains active in defending hospital insurers, reinsurers and brokers against clinical negligence claims. It hired consultant Emma Meagher, a specialist in women’s medical negligence, in October 2022. Tony McGovern is an experienced figure in life sciences transactions.
Key clients
- Aerogen
- Aspen Pharma
Work highlights
- Advised Head Diagnostics in relation to an investment by Enterprise Ireland following on from the successful completion of its 2022 Series A financing round.
- Acted for Berkshire Hathaway Speciality Insurance in a claim arising out of a procedure for coronary artery bypass graft.